CAS 1018448-65-1

Trastuzumab emtansine

CAS: 1018448-65-1

Trastuzumab emtansine is a HER2-targeted ADC for advanced breast cancer, combining trastuzumab with DM1 cytotoxicity.

Reinheit: 98%

Farbe und Form: Liquid

Ref: TM-T36647

Trastuzumab emtansine

CAS: 1018448-65-1

Antibody-drug conjugate (ADC) of HER2-targeted trastuzumab with cytotoxic microtubule-inhibitory agent DM1 (derivative of maytansine).

Ref: 3D-CLA1033